|
End-of-day quote
Shenzhen S.E.
2026-07-10
|
5-day change
|
1st Jan Change
|
|
12.17 CNY
|
+7.04%
|
 |
0.00%
|
-35.51%
|
|
04-27 |
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
|
CI
| |
04-27 |
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
|
CI
| |
25-10-29 |
Zhifei biological products' Q3 net loss at 601.1 million yuan
|
RE
| |
25-10-29 |
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
|
CI
| |
25-08-19 |
Chongqing Zhifei Biological Products Swings to Loss in H1 as Revenue Plunges 73%
|
MT
| |
25-08-18 |
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
|
CI
| |
25-08-18 |
Zhifei biological products h1 net loss at 597.1 million yuan
|
RE
| |
25-06-06 |
Zhifei Biological Products' Pneumonia Vaccine Enters Production Registration Review
|
MT
| |
25-06-03 |
Chinese Drug Regulator Accepts Chongqing Zhifei Biological Products' Application to Produce Meningococcal Vaccine
|
MT
| |
25-04-22 |
Zhifei Biological Products Falls to Q1 Loss as Revenue Falls 79%
|
MT
| |
25-04-22 |
Zhifei Biological Products' 2024 Profit Down 75%; Shares Fall 7%
|
MT
| |
25-04-21 |
Zhifei Biological Products Says 2024 Net Profit Down 75.0% Y/Y
|
RE
| |
25-04-21 |
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
|
CI
| |
25-04-21 |
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
|
CI
| |
24-12-18 |
Chongqing Zhifei Biological Products Co., Ltd. Announces Third Quarter 2024 Profit Distribution Plan (A Shares), Payable on 25 December 2024
|
CI
| |
24-12-09 |
Chongqing Zhifei Biological, GSK Adjust Terms of Cooperation Agreement
|
MT
| |
24-10-28 |
Chongqing Zhifei Biological Products Co., Ltd. Announces Profit Distribution Proposal for the Third Quarter of 2024
|
CI
| |
24-10-25 |
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
|
CI
| |
24-08-29 |
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024
|
CI
| |
24-08-21 |
Zhifei Biological Products' Unit Launches Clinical Trials on Pneumonia Vaccine
|
MT
| |
24-08-01 |
Chongqing Zhifei Biological Products Co., Ltd. Announces Final Dividend on A Shares, Payable on 08 August 2024
|
CI
| |
24-06-19 |
Chongqing Zhifei Biological Products Co., Ltd. Approves Cash Dividend for the Year 2023
|
CI
| |
24-04-23 |
Chongqing Zhifei Biological Products' 2023 Profit Rises 7%; Shares Plunge 12%
|
MT
| |
24-04-22 |
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
|
CI
| |
24-03-28 |
Tranche Update on Chongqing Zhifei Biological Products Co., Ltd.'s Equity Buyback Plan announced on February 22, 2024.
|
CI
|
No results match your criteria Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
Choose MarketScreener 
